How Poul was paid
$9.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Mojdeh PoulPresident and Chief Executive Officer and Director | $1,009,616 | $350,438 | $5,219,868 | $2,250,011 | $174,563 | $371,056 | $9,375,551 |
| Lea KnightExecutive Vice President and Chief Financial Officer | $638,646 | $154,897 | $1,498,719 | $499,574 | $77,158 | $14,000 | $2,882,994 |
| Robert T. Davis, JrExecutive Vice President, President, Tissue Technologies | $583,354 | $69,594 | $892,712 | $297,566 | $55,406 | $14,000 | $1,912,633 |
| Michael J. McBreenExecutive Vice President, President, Codman Specialty Surgical | $643,750 | $212,405 | $1,327,764 | $442,583 | $72,776 | $14,000 | $2,713,278 |
| Harvinder SinghExecutive Vice President, President, International | $563,993 | $91,194 | $683,126 | $227,704 | $45,426 | $14,000 | $1,625,444 |
| Jan De WitteFormer President and Chief Executive Officer and Director | $42,308 | — | — | — | — | $240,372 | $282,679 |
What changed and why
- $1.64BFull-year 2025 revenue reached $1.64 billion, representing a reported increase of 1.5% despite operational headwinds.
- $9.4MMojdeh Poul received total compensation of $9,375,551 in her first year as Chief Executive Officer.
- The CEO-to-median employee pay ratio was estimated at 110 to 1 for fiscal year 2025.
- 98.1%Stockholders expressed strong support for executive compensation with 98.1% approval at the 2025 annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.